The global histology & cytology market size surpassed at US$ 10.30 Bn in 2019 and to reach US$ 27 billion by 2027.
The global histology & cytology market is anticipated to grow at a CAGR of 9% during the forecast period 2020 to 2027. Increasing prevalence of cancer cases worldwide, advancements in pathological research, advent of digital technologies, along with growing support from governments are some of the key factors anticipated to drive the global histology & cytology market during the assessment period. Moreover, the integration of digital technologies such as AI will redefine the histology & cytology market landscape in the upcoming years, and boost efficiency and accuracy of pathological tests.
The global prevalence of cancer has been rising significantly, and the disease is considered the second major cause of death after cardiovascular diseases. Various factors contributing to the rise in the prevalence of cancer include urbanization, tobacco smoking, increasing pollution, changing diet patterns, and increase in the post-reproductive life span. According to the National Cancer Institute, over 1,806,590 new cases of cancer are anticipated to be diagnosed in the U.S. in 2020. Cervical cancer poses a significant threat to the female population in developing regions, and hence prevention as well as control of cervical cancer could be possible by early screening and diagnosis. Therefore, early detection of cervical cancer would improve the survival rate and quality of life of the patients, as it can be treated successfully with various treatment modalities. According to the World Health Organization (WHO), most of the cancer cases are detected in the final stage when they are not curable, especially in developing regions.
Reimbursement for Cancer Screening
Integration of Digital Technologies to Shape Future of Pathology
Pathology is one of the key elements of the global healthcare ecosystem and in the current day and age, traditional pathological techniques are gradually being replaced with advanced and modern pathological advancements. The onset of digital technologies is likely to shape the future of the global histology & cytology market in terms of boosting efficiency and scalability. Furthermore, the growing adoption of digital technologies is expected to accelerate the speed and accuracy of diagnosis due to which, the concept of digital pathology is gaining considerable traction worldwide.
The growing adoption of digital whole-slide-imaging (WSI) enables pathologists to visualize and capture the complete tissue on the slide in comparison with the view provided by the microscope– a factor that is expected to improve the accuracy of pathological processes and minimize its subjectivity. Digital slides pave the way for computer-assisted quantitative analytics, speedier image search, and efficient retrieval of slides. The global histology & cytology market is expected to take the digital path in the upcoming years, as digital technologies continue to bridge the gap between medical experts and patients. The growing adoption of artificial intelligence (AI) is projected to provide fertile grounds for the growth to the players operating in the current histology & cytology market. Advancements in precision medicine and AI are anticipated to improve care delivery due to which, more number of pathologists around the world are increasing embracing digital technologies. This factor is likely to provide a boost to the global histology & cytology market during the assessment period.
Cytology to Dominate Global Market
In terms of type of examination, the global histology & cytology market has been bifurcated into histology and cytology. The cytology segment has been split into cervical cancer, breast cancer, oral cancer, and others. The cytology segment dominated the market in terms of revenue in 2019. Increase in cases of cancer and rise in demand for diagnosis of the disease boost the growth of the segment.
Instruments & Analysis Software System to be in Demand
Based on product, the global histology & cytology market has been categorized into instruments & analysis software system and consumables & reagents. The instruments & analysis software system dominated the global histology & cytology market in 2019. Rise in product launch for various technologically advanced devices fuels the growth of the segment. However, the consumables & reagents segment is anticipated to expand at the highest CAGR during the forecast period.
Microscopy Methods to Lead Global Market
In terms of test type, the global histology & cytology market has been classified into microscopy methods, flow cytometry, and molecular genetic methods. The microscopy methods segment has been segregated into cytochemistry & histochemistry and immunohistochemistry & immunofluorescence. The molecular genetic methods segment has been split into cytogenic tests, polymerase chain reaction, and others. The microscopy methods segment dominated the global histology & cytology market in 2019. Over the years, the prevalence of cancer has risen rapidly across the globe. According to GLOBOCAN, in 2018, the prevalence of cancer was 43.8 million globally (9.6 million cancer deaths were registered in the same year).
Hospitals and Clinics to be Major End User
Based on end user, the global histology & cytology market has been divided into hospitals & clinics, academic & research institutes, and others. The hospitals & clinics segment dominated the market in terms of revenue in 2019. Hospitals & clinics are especially meant only for detection of diseases. The availability of sophisticated instruments and favorable reimbursement policies for various treatments drive the segment.
North America to Dominate Global Market
The global histology & cytology market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2019, followed by Europe. North America accounted for a major share of the global histology & cytology market in 2019, owing to early adoption of advanced technologies and well-established healthcare infrastructure, and strategies adopted by key players. The histology & cytology market in Asia Pacific is likely to expand at a high CAGR from 2020 to 2030. Rise in prevalence of cancer across the region is projected to accelerate the growth of the market in the region.
Competition Landscape
Becton, Dickinson and Company, Danaher, and F. Hoffmann-La Roche Ltd. are the three major companies operating in the global histology & cytology market. The global histology & cytology market is fragmented in terms of number of players. Key players in the global market include Abbott, Becton, Dickinson and Company, Danaher, F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, PerkinElmer, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare. New product development through robust R&D activities and merger & acquisitions are the key strategies adopted by these players to operate business in the global histology & cytology market.
Market Segmentation
By Type of Examination
By Product
By Test Type
By End User
By Region
Scope of the Report
VRR’s report on the global histology & cytology market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global histology & cytology market for the period 2018–2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global histology & cytology market from 2020 to 2030.
The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global histology & cytology market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global histology & cytology market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global histology & cytology market. These serve as valuable tools for existing market players as well as entities interested in participating in the global histology & cytology market.
The report also delves into the competition landscape of the global histology & cytology market. Key players operating in the global histology & cytology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global histology & cytology market that have been profiled in this report
Key Questions Answered in Histology & Cytology Report
Research Objectives and Research Approach
The comprehensive report on the global histology & cytology market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global histology & cytology market in terms of type of examination, test type, product, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global histology & cytology market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Histology & Cytology Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Histology & Cytology Market Analysis and Forecast, 2018–2027
5. Market Outlook
5.1. COVID-19 Pandemics Impact on Industry
5.2. Regulatory Scenario by Region/globally
5.3. Cancer Prevalence & Incidence Rate globally with key countries
5.4. Technological Advancements
6. Global Histology & Cytology Market Analysis and Forecast, by Type of Examination
6.1. Introduction & Definition
6.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2027
6.2.1. Histology
6.2.2. Cytology
6.2.2.1. Cervical Cancer
6.2.2.2. Breast Cancer
6.2.2.3. Oral Cancer
6.2.2.4. Others
6.3. Global Histology & Cytology Market Attractiveness Analysis, by Type of Examination
7. Global Histology & Cytology Market Analysis and Forecast, by Product
7.1. Introduction & Definition
7.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2027
7.2.1. Instruments & Analysis Software System
7.2.2. Consumables & Reagents
7.3. Global Histology & Cytology Market Attractiveness Analysis, by Product
8. Global Histology & Cytology Market Analysis and Forecast, by Test Type
8.1. Introduction & Definition
8.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2027
8.2.1. Microscopy methods
8.2.1.1. Cytochemistry & Histochemistry
8.2.1.2. Immunohistochemistry & Immunofluoroscence
8.2.2. Flow Cytometry
8.2.3. Molecular Genetic Methods
8.2.3.1. Cytogenic Tests
8.2.3.2. Polymerase Chain Reaction
8.2.3.3. Others
8.3. Global Histology & Cytology Market Attractiveness Analysis, by Test Type
9. Global Histology & Cytology Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2027
9.2.1. Hospitals & Clinics
9.2.2. Academic & Research Institutes
9.2.3. Others
9.3. Global Histology & Cytology Market Attractiveness Analysis, by End-user
10. Global Histology & Cytology Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Histology & Cytology Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Histology & Cytology Market Attractiveness Analysis, by Region
11. North America Histology & Cytology Market Analysis and Forecast
11.1. Introduction
11.2. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2027
11.2.1. Histology
11.2.2. Cytology
11.2.2.1. Cervical Cancer
11.2.2.2. Breast Cancer
11.2.2.3. Oral Cancer
11.2.2.4. Others
11.3. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2027
11.3.1. Instruments & Analysis Software System
11.3.2. Consumables & Reagents
11.4. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2027
11.4.1. Microscopy Methods
11.4.1.1. Cytochemistry & Histochemistry
11.4.1.2. Immunohistochemistry & Immunofluoroscence
11.4.2. Flow Cytometry
11.4.3. Molecular Genetic Methods
11.4.3.1. Cytogenic Tests
11.4.3.2. Polymerase Chain Reaction
11.4.3.3. Others
11.5. North America Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2027
11.5.1. Hospitals & Clinics
11.5.2. Academic & Research Institutes
11.5.3. Others
11.6. North America Histology & Cytology Market Value (US$ Mn) Forecast, by Country, 2018–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Histology & Cytology Market Attractiveness Analysis
11.7.1. By Type of Examination
11.7.2. By Product
11.7.3. By Test Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Histology & Cytology Market Analysis and Forecast
12.1. Introduction
12.2. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2027
12.2.1. Histology
12.2.2. Cytology
12.2.2.1. Cervical Cancer
12.2.2.2. Breast Cancer
12.2.2.3. Oral Cancer
12.2.2.4. Others
12.3. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2027
12.3.1. Instruments & Analysis Software System
12.3.2. Consumables & Reagents
12.4. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2027
12.4.1. Microscopy methods
12.4.1.1. Cytochemistry & Histochemistry
12.4.1.2. Immunohistochemistry & Immunofluoroscence
12.4.2. Flow Cytometry
12.4.3. Molecular Genetic Methods
12.4.3.1. Cytogenic Tests
12.4.3.2. Polymerase Chain Reaction
12.4.3.3. Others
12.5. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2027
12.5.1. Hospitals & Clinics
12.5.2. Academic & Research Institutes
12.5.3. Others
12.6. Europe Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Histology & Cytology Market Attractiveness Analysis
12.7.1. By Type of Examination
12.7.2. By Product
12.7.3. By Test Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Histology & Cytology Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2027
13.2.1. Histology
13.2.2. Cytology
13.2.2.1. Cervical Cancer
13.2.2.2. Breast Cancer
13.2.2.3. Oral Cancer
13.2.2.4. Others
13.3. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2027
13.3.1. Instruments & Analysis Software System
13.3.2. Consumables & Reagents
13.4. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2027
13.4.1. Microscopy Methods
13.4.1.1. Cytochemistry & Histochemistry
13.4.1.2. Immunohistochemistry & Immunofluoroscence
13.4.2. Flow Cytometry
13.4.3. Molecular Genetic Methods
13.4.3.1. Cytogenic Tests
13.4.3.2. Polymerase Chain Reaction
13.4.3.3. Others
13.5. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2027
13.5.1. Hospitals & Clinics
13.5.2. Academic & Research Institutes
13.5.3. Others
13.6. Asia Pacific Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Histology & Cytology Market Attractiveness Analysis
13.7.1. By Type of Examination
13.7.2. By Product
13.7.3. By Test Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Histology & Cytology Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Type of Examination, 2018–2027
14.2.1. Histology
14.2.2. Cytology
14.2.2.1. Cervical Cancer
14.2.2.2. Breast Cancer
14.2.2.3. Oral Cancer
14.2.2.4. Others
14.3. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2027
14.3.1. Instruments & Analysis Software System
14.3.2. Consumables & Reagents
14.4. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2027
14.4.1. Microscopy Methods
14.4.1.1. Cytochemistry & Histochemistry
14.4.1.2. Immunohistochemistry & Immunofluoroscence
14.4.2. Flow Cytometry
14.4.3. Molecular Genetic Methods
14.4.3.1. Cytogenic Tests
14.4.3.2. Polymerase Chain Reaction
14.4.3.3. Others
14.5. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2027
14.5.1. Hospitals & Clinics
14.5.2. Academic & Research Institutes
14.5.3. Others
14.6. Latin America Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Histology & Cytology Market Attractiveness Analysis
14.7.1. By Type of Examination
14.7.2. By Product
14.7.3. By Test Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
14.8. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Product, 2018–2027
14.8.1. Instruments & Analysis Software System
14.8.2. Consumables & Reagents
14.9. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Test Type, 2018–2027
14.9.1. Microscopy Methods
14.9.1.1. Cytochemistry & Histochemistry
14.9.1.2. Immunohistochemistry & Immunofluoroscence
14.9.2. Flow Cytometry
14.9.3. Molecular Genetic Methods
14.9.3.1. Cytogenic Tests
14.9.3.2. Polymerase Chain Reaction
14.9.3.3. Others
14.10. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by End-user, 2018–2027
14.10.1. Hospitals & Clinics
14.10.2. Academic & Research Institutes
14.10.3. Others
14.11. Middle East & Africa Histology & Cytology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2027
14.11.1. GCC Countries
14.11.2. South Africa
14.11.3. Rest of Middle East & Africa
14.12. Middle East & Africa Histology & Cytology Market Attractiveness Analysis
14.12.1. By Type of Examination
14.12.2. By Product
14.12.3. By Test Type
14.12.4. By End-user
14.12.5. By Country/Sub-region
15. Competition Landscape
15.1. Market Position Analysis, by Company, 2019
15.2. Company Profiles
15.2.1. Abbott
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Growth Strategies
15.2.1.3. SWOT Analysis
15.2.2. Becton Dickinson and Company
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Growth Strategies
15.2.2.3. SWOT Analysis
15.2.3. Danaher
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Growth Strategies
15.2.3.3. SWOT Analysis
15.2.4. F. Hoffmann-La Roche Ltd.
15.2.4.1. Company Overview (HQ, Business Segments)
15.2.4.2. Growth Strategies
15.2.4.3. SWOT Analysis
15.2.5. Hologic, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Growth Strategies
15.2.5.3. SWOT Analysis
15.2.6. Merck KGaA
15.2.6.1. Company Overview (HQ, Business Segments)
15.2.6.2. Growth Strategies
15.2.6.3. SWOT Analysis
15.2.7. PerkinElmer Inc.
15.2.7.1. Company Overview (HQ, Business Segments)
15.2.7.2. Growth Strategies
15.2.7.3. SWOT Analysis
15.2.8. Sysmex Corporation
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Growth Strategies
15.2.8.3. SWOT Analysis
15.2.9. Thermo Fisher Scientific Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Growth Strategies
15.2.9.3. SWOT Analysis
15.2.10. Trivitron Healthcare
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Company Financials
15.2.10.3. Growth Strategies
15.2.10.4. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers